PRKN and cancer: Mechanistically, lipid peroxidation‐ATF4‐Parkin pathway‐mediated mitophagy limits lipid peroxidation to halt ferroptosis in cancer, and mitophagy deficiency strongly increases lipid peroxidation and enhances ferroptosis induced by erastin, RSL3, cysteine deprivation, radiotherapy or immunotherapy.